GAOMA Therapeutics will present its drug candidate GAO-3-02 at the Fifteenth EILAT Conference on New Antiepileptic Drugs and Devices (EILAT XV), organized on July 27th-August 3rd, 2020.
The EILAT Conference is an international event of reference, providing every two years an in-depth progress report on new antiepileptic drugs in various stages of development, as well as new findings on second-generation treatments.